Fat Loss Peptide Stack UAE 2026: AOD9604 + CJC-1295 + GLP-1 Protocol
Fat Loss Peptide Stack UAE 2026: AOD9604 + CJC-1295/Ipamorelin + GLP-1 Protocol
The most effective fat loss peptide research protocols combine compounds that attack adipose tissue through multiple independent pathways simultaneously — lipolysis stimulation, GH pulsatile enhancement, appetite suppression, and metabolic rate increase. This guide describes the research-backed fat loss stack used by UAE-based researchers in 2026.
Stack Architecture: Three Independent Pathways
1. AOD9604 — Direct Lipolysis Activation
Dose: 250–500 mcg subcutaneous injection, before morning cardio or fasted
Frequency: Daily or 5× per week
Mechanism: AOD9604 is the C-terminal fragment of HGH (176-191) — it retains HGH's fat-metabolising properties (β3-adrenergic receptor stimulation → lipolysis) without the growth-promoting or blood glucose-altering effects of full HGH. It stimulates fat breakdown directly in adipocytes without requiring elevated insulin or cortisol.
2. CJC-1295 + Ipamorelin — GH Pulse Enhancement
Dose: CJC-1295 (no DAC) 100–200 mcg + Ipamorelin 100–200 mcg
Timing: 30–45 minutes before sleep (amplifies natural nocturnal GH pulse)
Mechanism: The GHRH + GHRP combination produces a synergistic GH pulse 3–5× greater than either alone. Elevated GH during sleep shifts substrate utilisation toward fat oxidation and stimulates IGF-1 production — improving body composition through lipolysis and lean mass preservation simultaneously.
3. GLP-1/GIP Agonist — Appetite Suppression + Metabolic
Option A (Tirzepatide): 2.5mg → 5mg → 10mg → 15mg weekly titration
Option B (Retatrutide): 1mg → 4mg → 8mg → 12mg weekly titration
Option C (Acetyl GLP-1+GIP): 5–10mg vial, research dosing
Mechanism: GLP-1/GIP receptor agonism suppresses hypothalamic appetite centres, slows gastric emptying, and at the GIPR level, enhances thermogenesis and energy expenditure. This addresses the caloric intake and metabolic rate components of fat loss that AOD9604 and GH peptides do not directly target.
Combined Weekly Protocol
| Time | Compound | Purpose |
|---|---|---|
| Morning (fasted) | AOD9604 250–500 mcg SC | Direct lipolysis — peak effect with low insulin |
| Pre-sleep | CJC-1295 + Ipamorelin SC | Nocturnal GH pulse amplification |
| Once weekly (SC) | Tirzepatide or Retatrutide | Sustained appetite suppression + metabolic |
Expected Research Outcomes
- Weeks 1–4: Appetite reduction evident from GLP-1 agonist; water weight changes from GH peptides; initial improved sleep quality
- Weeks 4–8: Measurable fat mass reduction; improved fasting glucose; lean mass preservation or improvement from GH peptide effect
- Weeks 8–16: Significant body composition changes; continued fat loss; IGF-1 elevation detectable in bloodwork
Products in This Stack
Build Your Fat Loss Stack in Dubai
AOD9604, CJC-1295 + Ipamorelin blends, Retatrutide — all in stock with same-week shipping.
Shop Fat Loss PeptidesFAQ
No — this is AOD9604's key advantage over full HGH. The 176-191 fragment retains lipolytic activity via β3-adrenergic signalling but does not stimulate IGF-1 production or glucose elevation. Research in obese subjects showed no significant changes in blood glucose or insulin at standard research doses.
Yes — they target different receptors (GHRH-R and ghrelin receptor respectively). When taken together within 30 minutes of each other, they produce a synergistic GH pulse 3–5× the amplitude of either alone. Taking them separately does not produce this synergy.
CoreSup stocks pharmaceutical-grade bacteriostatic water (10ml, 0.9% benzyl alcohol) with same-day delivery across Dubai and all UAE emirates.
Shop Bacteriostatic Water →Disclaimer: This article is for educational and research purposes only. All compounds mentioned are research peptides not approved for human therapeutic use by UAE MOHAP or the FDA. Stack protocols described represent research designs, not medical prescriptions. Consult a licensed UAE healthcare professional before beginning any protocol.
Written by Core Sup Research Team
Core Sup Research Team · Peptide & Supplement Specialists, Dubai UAE
Core Sup's editorial team is composed of specialists in peptide therapy, SARMs, and sports supplementation with direct experience in the UAE market. All content is written to current research standards and reviewed before publication.
Last reviewed: April 2026 · About Core Sup
